Assertio Therapeutics, Inc


Assertio Therapeutics, Inc Stock Quote
$1.29 -$0.05 -3.7%
Price as of February 18, 2020, 4:30 p.m. EST View Interactive ASRT Charts

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.

Interactive Chart

News & Analysis: Assertio Therapeutics, Inc

The Fool has written over 100 articles on Assertio Therapeutics, Inc.


Market Moves


Why Depomed Inc. Stock Spiked Today

The drugmaker is reportedly drawing buyout interest from KKR & Co., upping the possibility that a sale is finally imminent.